Research Fields, Keywords

Targeted Radionuclide Therapy, Molecular imaging

Mail Address

E-mail address

Laboratory Phone number


Laboratory Fax number


Current Affiliation Organization 【 display / non-display

  • Duty ,  Fukushima Global Medical Science Center ,  Advanced Clinical Research Center ,  Professor

Graduate School 【 display / non-display

  • Gunma University ,  Graduate School, Division of Medical Sciences ,  Doctor's Course ,  Completed ,  JAPAN ,  1991.03

Academic Society Affiliations 【 display / non-display


Field of expertise (Grants-in-aid for Scientific Research classification) 【 display / non-display

  • Radiation science

Qualification acquired 【 display / non-display

  • Doctor

Current state of research and teaching activities 【 display / non-display

  • Medicine


Papers 【 display / non-display

  • Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.

    Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Tsuya A, Nakamura Y, Naito T, Hayashi I, Serizawa M, Koh Y, Hanaoka H, Tominaga H, Oriuchi N, Kondo H, Nakajima T, Yamamoto N

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology ,  28 (23) 3746 - 53 ,  2010.08

    Multiple Authorship ,  ISBN: 0732-183X

    DOI PubMed

  • Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.

    Kaira K, Oriuchi N, Otani Y, Shimizu K, Tanaka S, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Dobashi K, Kanai Y, Endou H, Nakajima T, Endo K, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research ,  13 (21) 6369 - 78 ,  2007.11

    Multiple Authorship ,  ISBN: 1078-0432

    DOI PubMed

  • Different biodistribution of 99mTc-labeled chimeric mouse-human monoclonal antibody between athymic mice model and human

    Oriuchi N, Watanabe N, Sugiyama S, Higuchi T, Imai K, Yamanaka H, Hashimoto M, Kanda H, Endo K

    Br J Cancer ,  73:   1466 - 1472 ,  1996

    Multiple Authorship

  • 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer.

    Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Mori M, Endo K

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine ,  50 (11) 1770 - 6 ,  2009.11

    Multiple Authorship ,  ISBN: 0161-5505

    DOI PubMed

  • Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.

    Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Tanaka S, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

    Br J Cancer. ,  8 (4) 742 - 8 ,  2008

    Multiple Authorship


display all >>

Books 【 display / non-display

  • Frontier of Antibody Engineering for Next-generation Theranostics

    Izumi Kumagai (Part:Present status and future prospect of radiopharmaceuticals) (Page:171-175)

    CMC Books Co. ,  2019.09 ,  ISBN: 978-4-7813-1378-8

    Oriuchi Noboru ,  Tokyo

  • Perfect guide of urological examination

    Oya Mototsugu, Kondo Yukihiro, Kojima Yoshiyuki (Part:Radionuclide Renography) (Page:64-66)

    Igaku-shoin ,  2017.04

    Oriuchi Noboru ,  Tokyo

  • Perfect guide of urological examination

    Oya Mototsugu, Kondo Yukihiro, Kojima Yoshiyuki (Part:FDG-PET/CT) (Page:74-76)

    Igaku-shoin ,  2017.04

    Oriuchi Noboru ,  Tokyo

Joint Research activities 【 display / non-display

  • Analyses of chromosomal abnormality in normal somatic cells induced by alpha-particle therapy

    Collaboration in College  

    Project Year:2019.04 - 2021.03 

    Investigator(s): Oriuchi Noboru 

  • Innovative brain tumor diagnosis using C-11 methionine PET for Precision Medicine


    Project Year:2017.04 - 2019.03 

    Investigator(s): Shiga Tohru  ,  Member: Oriuchi Noboru,

Presentations 【 display / non-display

  • Radiolabeling and biodistribution in the tumor xenograft of 211At-labeled anti-CXCR4 antibody for cancer stem cell targeted alpha-particle therapy

    32nd Annual Congress of the European Association of Nuclear Medicine , 


  • Theranostics in Japan and current status of Fukushima Medical University

    Theranostics World Congress 2019 , 


  • Targeted Alpha Therapy in Japan - Where we are in 2018 –

    EANM’19 , 


  • α線放出核種によるがん治療の進歩と国内における研究開発

    日本放射線腫瘍学会第31回学術大会 , 


  • FDG-PET読影の基礎

    第12回PET-CT読影実践セミナー , 


display all >>